TLRY vs TLSIW
Tilray Inc (TLRY) versus TriSalus Life Sciences Inc. (TLSIW) — a side-by-side from cached financials, not a winner call.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
TriSalus Life Sciences Inc. (TLSIW) common stock listed on NASDAQ.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
TLSIW does not have a complete income-statement cache yet.
TLRY currently screens at market cap $573.9M. TLSIW currently screens at market cap $0.
Not investment advice. Open the TLRY and TLSIW stock pages for the full models.
Not investment advice.